col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


47 Results       Page 1

 [1] 
Springer (Biomed Central Ltd.): Egyptian Journal of Medical Human Genetics
  original article Date Title Authors   All Authors
1 [GO] 2026―Feb―06 Association of TNF-⍺ promoter polymorphisms with COVID-19 susceptibility and severity: a study from South India M. L. N. Deepika, Aryan Gupta, C. Lalitha Pavani
2 [GO] 2025―Oct―18 Association between complement system, pulmonary fibrosis, and ABO system gene variants and COVID-19 severity and susceptibility: a Moroccan case-control study Fatima-Zahra El Yousfi, Chaimae Nebhani, Hamza Ghammaz, Reda Benmansour, Hanaa Skhoun, Khalid Ennibi, et al. (+4)
3 [GO] 2025―Aug―27 Expression levels of taste genes, TAS1R1, TAS1R2 and TAS1R3 among SARS-CoV-2 patients Emad Behboudi, Mojtaba Rasti, Riam Sadooni, Masoumeh Ghasemnezhad, Asma Mohammadi, Samaneh Abbasi
4 [GO] 2025―Feb―22 Adoptive transfer of natural killer cells in therapeutic treatment of COVID-19 patients Abdulaziz Alamri
5 [GO] 2024―Nov―09 The IFIH1 gene variants rs1990760 and rs2111485 are associated with COVID-19 susceptibility and affect IFIH1 protein levels in Iraqis Abdulraheem Y. Majeed, Nor Effa S. Zulkafli, Ali H. Ad’hiah
6 [GO] 2024―Oct―16 Predictors of COVID-19 severity among a cohort of Egyptian patients Mona Fathy, Samar Moemen, Dalia Hamed, Shadia Hussein, Wafaa Ashour, Omar Ashoush, et al. (+4)
7 [GO] 2024―Aug―05 Exploring potential therapeutic strategy for hepatocellular carcinoma and COVID-19 using bioinformatics analysis Jiayan Tang, Zaiyong Yang, Huotang Qin, Yu Huang, Minqing Li, Qing Deng, et al. (+2)
8 [GO] 2024―Jul―02 Preliminary study: nutrigenomics analysis results of COVID-19 survivors Anna Surgean Veterini, Bambang Pujo Semedi, Prananda Surya Airlangga, Khildan Miftahul Firdaus, Akhyar Nur Uhud, Prihatma Kriswidyatomo, Rauzan Sumara
9 [GO] 2024―Jan―24 Association of common variant rs9934336 of SLC5A2 (SGLT2) gene with SARS-CoV-2 infection and mortality Anamika Das, Gunanidhi Dhangadamajhi
10 [GO] 2023―Dec―11 Evaluation of therapeutic potentials of some bioactive compounds in selected African plants targeting main protease (Mpro) in SARS-CoV-2: a molecular docking study Ishola Abeeb Akinwumi, Barakat Olamide Ishola, Oluwatosin Maryam Adeyemo, Adefolarin Phebean Owojuyigbe
11 [GO] 2023―Oct―30 The role of miRNA20a and miRNA320 in Iraqi patients with COVID-19: a case-control study Reema Mohammed Abed, Hadeel Waleed Abdulmalek, Laith Ahmad Yaaqoob
12 [GO] 2023―May―29 Association between leukocyte telomere length and COVID-19 severity Ata Mahmoodpoor, Sarvin Sanaie, Maqsoud Eskandari, Nazila Behrouzi, Majid Taghizadeh, Faranak Roudbari, et al. (+3)
13 [GO] 2023―Jan―26 The role of HLA genotypes in understanding the pathogenesis of severe COVID-19 Fatemeh Arab, Samaneh Mollazadeh, Farnaz Ghayourbabaei, Meysam Moghbeli, Ehsan Saburi
14 [GO] 2023―Jan―22 HLA alleles associated with COVID-19 susceptibility and severity in different populations: a systematic review Meryem Fakhkhari, Hayat Caidi, Khalid Sadki
15 [GO] 2023―Jan―09 Genetic diversity of Mycobacterium tuberculosis isolates from northwest of Iran during COVID-19 era Peyvand Kashi, Farzaneh Pakdel, Mohammad Hossein Soroush Barhaghi, Mohammad Ahangarzadeh Rezaee, Sepehr Taghizadeh, Javid Sadeghi, et al. (+5)
16 [GO] 2022―Oct―20 A systems biology approach for investigating significantly expressed genes among COVID-19, hepatocellular carcinoma, and chronic hepatitis B Babak Sokouti
17 [GO] 2022―Oct―01 Implication of single nucleotide polymorphisms in Interleukin-10 gene (rs1800896 and rs1800872) with severity of COVID-19 Saliha Rizvi, S. Mohd.Shiraz Rizvi, Syed Tasleem Raza, Mohd. Abbas, Kaynat Fatima, Zeashan H. Zaidi, Farzana Mahdi
18 [GO] 2022―Sep―23 Dipyridamole and adenosinergic pathway in Covid-19: a juice or holy grail Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Engy Elekhnawy, Gaber El-Saber Batiha
19 [GO] 2022―Sep―15 Lysosomal storage diseases in the era of COVID-19: a report of an Egyptian case of alpha-fucosidosis and a summary of the lysosomal storage diseases-COVID-19 relationship Heba Saed El-Amawy, Heba Dawoud
20 [GO] 2022―Aug―23 Association between single nucleotide polymorphism of human angiotensin-converting enzyme 2 gene locus and clinical severity of COVID-19 Shaimaa A. Elbadri, Nermeen M. A. Abdallah, Mona El-Shokry, Amr Gaber, Mahmoud Kh. Elsayed
21 [GO] 2022―Aug―03 Characterization of the expressed RNA variants from young patients with critical and non-critical SARS-CoV-2 infection Javan Okendo
22 [GO] 2022―Jun―19 Understanding the pivotal roles of ACE2 in SARS-CoV-2 infection: from structure/function to therapeutic implication Amir Pouremamali, Abouzar Babaei, Somayeh Shatizadeh Malekshahi, Ardeshir Abbasi, Nastaran Rafiee
23 [GO] 2022―May―28 The role of angiotensin-converting enzyme 2 (ACE2) genetic variations in COVID-19 infection: a literature review Manal S. Fawzy, Hend Ashour, Aya Allah Ashraf Shafie, Nesrine Ben Hadj Dahman, Abdelhamid M. Fares, Sarah Antar, et al. (+2)
24 [GO] 2022―Apr―28 Investigating expressed RNA variants that are related to disease severity in SARS-CoV-2-infected patients with mild-to-severe disease Javan Okendo, David Okanda
25 [GO] 2022―Mar―25 The potential application of probiotics for the prevention and treatment of COVID-19 Engy Elekhnawy, Walaa A. Negm
26 [GO] 2022―Mar―16 Influence of COVID-19 pandemic lockdown on a sample of Egyptian children with Down syndrome Nagwa A. Meguid, Neveen Hassan Nashaat, Hanaa Reyad Abdallah, Maha Hemimi, Ahmed Elnahry, Hazem Mohamed El-Hariri, Amal Elsaeid
27 [GO] 2022―Mar―07 The role of tumor necrosis factor alpha - 308A > G polymorphism on the clinical states of SARS-CoV-2 infection Francisco Sotomayor-Lugo, Claudia Alemañy-Díaz Perera, Hilda Roblejo-Balbuena, Yaíma Zúñiga-Rosales, Giselle Monzón-Benítez, Beatriz Suárez-Besil, et al. (+8)
28 [GO] 2022―Mar―04 SARS-CoV-2 origin, myths and diagnostic technology developments Josephine Wambani, Patrick Okoth
29 [GO] 2022―Feb―04 Design of a multi-epitope-based peptide vaccine against the S and N proteins of SARS-COV-2 using immunoinformatics approach Arian Karimi Rouzbahani, Farnaz Kheirandish, Seyedeh Zeinab Hosseini
30 [GO] 2022―Jan―30 Coronavirus-linked pregnancy complications: a comparative study Miapeh Kous Gonlepa, Olayemi Hafeez Rufai, Chidinmma Grace Ofuonye, Lapologang Sebaka
31 [GO] 2022―Jan―21 Morbidity and mortality of COVID-19 negatively associated with the frequency of consanguineous marriages, an ecologic study Mostafa Saadat
32 [GO] 2022―Jan―20 ABO blood grouping and COVID-19: a hospital-based study in Eastern India Birasen Behera, Bidyutprava Rout, Subrat Kumar Kar, Debasish Sahoo, Kundan Kumar Sahu, Sarita Otta
33 [GO] 2022―Jan―10 Oral cavity infection by the SARS-CoV-2: emphasizing the essence of masking and peptide therapeutics Glory Omini Ibiang, Joseph Malachi, Mercy Omini Ibiang, Daniel Kenechi Chukwudi, Olanrewaju Ayodeji Durojaye
34 [GO] 2021―Nov―30 TaqI polymorphism of the VDR gene: aspects related to the clinical behavior of COVID-19 in Cuban patients Estela Morales Peralta, Yaíma Zúñiga Rosales, Teresa Collazo Mesa, Elvia Nelmi Santos González, Yadira Hernández Pérez, María de los Ángeles González Torres, et al. (+2)
35 [GO] 2021―Nov―26 Coronavirus disease 19 and risk of hyperglycemia among Iraqi patients Ali H. Ad’hiah, Noor T. Al-Bayatee, Aeshah A. Ahmed
36 [GO] 2021―May―07 Characterization of the SARS-CoV-2 coronavirus X4-like accessory protein Olanrewaju Ayodeji Durojaye, Nkwachukwu Oziamara Okoro, Arome Solomon Odiba
37 [GO] 2021―Jan―05 Susceptibility to the novel coronavirus disease (COVID-19) is associated with ABO and Rh blood groups: a case-control study from Afghanistan Khyber Saify, Mohammad Sarwar Alborz, Mostafa Saadat
38 [GO] 2020―Dec―31 Understanding the genetic determinant of severity in viral diseases: a case of SARS-Cov-2 infection Babayemi Olawale Oladejo, Covenant Femi Adeboboye, Tinuola Tokunbo Adebolu
39 [GO] 2020―Dec―17 Association between ABO blood groups and susceptibility to COVID-19: profile of age and gender in Iraqi patients Ali H. Ad’hiah, Maha H. Abdullah, Mustafa Y. Alsudani, Rasool M. S. Shnawa, Ali J. R. Al-Sa’ady, Risala H. Allami, et al. (+3)
40 [GO] 2020―Dec―16 Low iron mitigates viral survival: insights from evolution, genetics, and pandemics-a review of current hypothesis Rahma Menshawey, Esraa Menshawey, Ayman H. K. Alserr, Antoine Fakhry Abdelmassih
41 [GO] 2020―Dec―09 Contributory role of SARS-CoV-2 genomic variations and life expectancy in COVID-19 transmission and low fatality rate in Africa Olabode E. Omotoso
42 [GO] 2020―Nov―25 An in silico LLPS perturbation approach in the design of a novel SARS-CoV-2 spike receptor-binding domain inhibitor Olanrewaju Ayodeji Durojaye, Divine Mensah Sedzro, Talifhani Mushiana, Henrietta Onyinye Uzoeto, Samuel Cosmas, Judith Nnedimkpa Ajima, Glory Omini Ibiang
43 [GO] 2020―Oct―01 Potential therapeutic target identification in the novel 2019 coronavirus: insight from homology modeling and blind docking study Olanrewaju Ayodeji Durojaye, Talifhani Mushiana, Henrietta Onyinye Uzoeto, Samuel Cosmas, Victor Malachy Udowo, Abayomi Gaius Osotuyi, et al. (+2)
44 [GO] 2020―Sep―30 The morbidity and mortality of COVID-19 are correlated with the Ile105Val glutathione S-transferase P1 polymorphism Mostafa Saadat
45 [GO] 2020―Sep―20 COVID-19 susceptibility: potential of ACE2 polymorphisms Mayank Chaudhary
46 [GO] 2020―Sep―10 Evaluating of the association between ABO blood groups and coronavirus disease 2019 (COVID-19) in Iraqi patients Ali H. Ad’hiah, Risala H. Allami, Raghdan H. Mohsin, Maha H. Abdullah, Ali J. R. AL-Sa’ady, Mustafa Y. Alsudani
47 [GO] 2020―Jul―26 An in silico epitope-based peptide vaccine design against the 2019-nCoV Olanrewaju Ayodeji Durojaye, Talifhani Mushiana, Samuel Cosmas, Glory Omini Ibiang, Mercy Omini Ibiang
 [1] 

47 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.004 sec